Valuation: Alcon

Market Cap 35.28B 30.28B 28.38B 25.96B 48.94B 3,366B 49.19B 336B 130B 1,697B 132B 130B 5,619B P/E 2026 *
43.8x
P/E 2027 * 26.6x
Enterprise Value 37.82B 32.46B 30.42B 27.83B 52.47B 3,609B 52.74B 360B 140B 1,820B 142B 139B 6,024B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.12x
Free-Float
97.34%
Yield 2026 *
0.5%
Yield 2027 * 0.56%
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 35.35B
+0.03%-2.87%-40.86%-8.53% 85.36B
-0.20%-2.88%-10.51%-20.42% 35.35B
-0.49%-4.07%-1.09%-21.72% 14.25B
-1.34%+1.18% - - 11.96B
-0.76%+9.74%-10.58%+743.48% 2.78B
+2.33%-2.66%-42.86%-56.92% 1.46B
+1.78%+3.04%+16.95%+10.70% 897M
-0.58%-1.30%+51.48%-8.18% 890M
+0.15%+3.10% - - 890M
Average +0.09%+1.03%-5.35%+91.20% 17.09B
Weighted average by Cap. -0.13%-1.61%-27.70%+1.59%

Financials

2026 *2027 *
Net sales 11.09B 9.52B 8.92B 8.16B 15.38B 1,058B 15.46B 106B 41.01B 534B 41.63B 40.73B 1,766B 11.77B 10.1B 9.47B 8.66B 16.33B 1,123B 16.42B 112B 43.54B 566B 44.2B 43.24B 1,875B
Net income 764M 656M 615M 562M 1.06B 72.91B 1.07B 7.27B 2.83B 36.77B 2.87B 2.81B 122B 1.26B 1.08B 1.01B 926M 1.75B 120B 1.76B 11.98B 4.66B 60.57B 4.73B 4.62B 201B
Net Debt 2.54B 2.18B 2.05B 1.87B 3.53B 243B 3.55B 24.22B 9.41B 122B 9.55B 9.35B 405B 1.45B 1.24B 1.17B 1.07B 2.01B 138B 2.02B 13.8B 5.36B 69.76B 5.44B 5.33B 231B
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA